367 related articles for article (PubMed ID: 27001074)
1. Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.
Tetz G; Vikina D; Tetz V
Ann Clin Microbiol Antimicrob; 2016 Mar; 15():19. PubMed ID: 27001074
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
3. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
5. Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients.
Michon AL; Jumas-Bilak E; Chiron R; Lamy B; Marchandin H
PLoS One; 2014; 9(2):e90164. PubMed ID: 24587256
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
Strateva T; Petrova G; Mitov I
J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
[TBL] [Abstract][Full Text] [Related]
7. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
[TBL] [Abstract][Full Text] [Related]
9. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand.
Tunyapanit W; Pruekprasert P; Laoprasopwattana K; Chelae S
Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):273-80. PubMed ID: 23691637
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
[TBL] [Abstract][Full Text] [Related]
12. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
Shang D; Meng X; Zhang D; Kou Z
Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
[TBL] [Abstract][Full Text] [Related]
14. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
[TBL] [Abstract][Full Text] [Related]
15. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
Viganor L; Galdino AC; Nunes AP; Santos KR; Branquinha MH; Devereux M; Kellett A; McCann M; Santos AL
J Antimicrob Chemother; 2016 Jan; 71(1):128-34. PubMed ID: 26416778
[TBL] [Abstract][Full Text] [Related]
16. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
17. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.
Alipour M; Omri A; Suntres ZE
Can J Physiol Pharmacol; 2011 Jun; 89(6):419-27. PubMed ID: 21815782
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
19. Natural isothiocyanates express antimicrobial activity against developing and mature biofilms of Pseudomonas aeruginosa.
Kaiser SJ; Mutters NT; Blessing B; Günther F
Fitoterapia; 2017 Jun; 119():57-63. PubMed ID: 28390975
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
Pye CC; Yu AA; Weese JS
Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
